Cord Blood America Inc. CBAI Archives - Page 4 of 4

WednesdayApr 18, 2007 3:59 am

Cord Blood America, Inc. (CBAI.OB) Releases Large 2006 Revenue Numbers, Gross Profits Reach New Heights

Cord Blood America completed their best quarter announcing $3.89 Million in revenues. This is a 71% increase compared to the $2.28 Million made in 2005, and is the third consecutive quarter topping the million dollar plateau. The company’s gross profit is up 37% from 2005 reaching $703,933 in 2006. Cord Blood America had an efficient year with net loss decreased significantly, in fact it dropped from $6.13 Million to $5.69 Million. The company also recorded a $2,112,505 interest expense, which accounted for approximately 35% of the loss. v Surprisingly, the large revenues did not include the recent acquisition of the…

ThursdayApr 12, 2007 5:54 am

Cord Blood America, Inc. (CBAI.OB) Receives a Large Institutional Investment

Cord Blood America has acquired $200,000 in capital from a leading institutional investment firm in New York City. The funds will be used to complete a potential acquisition mentioned in a Letter of Intent. The CEO of Cord Blood America stated that the debt placement minimizes dilution and protects their shareholders. He comments, “It’s easier to make acquisitions when you have the financing already secured.” Any company experiencing growth will require funds. The liability is expected to be promptly paid with cash flow from the anticipated acquisition. Let us hear your thoughts below:

TuesdayApr 10, 2007 7:52 am

Cord Blood America, Inc. (CBAI.OB) Begins Sponsorship on QualityStocks.Net

Cord Blood America has agreed to appear in QualityStock's Newsletters, Videos and Blog. QualityStocks.net is devoted to assist emerging public companies distribute their stories to the investment community. Cord Blood America is focused on discovering new development in the collection, testing, processing, and preservation of umbilical cord blood in the United States. The CEO and founder, Matt Schissler, commented on his company’s unique and solid business foundation. Cord Blood America is stimulating economy with new jobs and foreign investment and is excited to have the opportunity to be sponsored by QualityStocks. Michael McCarthy, the Director of Business Development for QualityStocks.net,…

MondayApr 09, 2007 6:59 am

White House Endorsement and Advances in Stem Cell Research Benefit Cord Blood America Inc. (CBAI. OB)

The recent signal from the White House is a very positive development for Cord Blood America Inc. (CBAI.OB). The Bush Administration endorsement, as a participant with Congress, in finding philosophical compromises to further medical research into stem cell therapies is a major leap forward. Cord Blood America, Inc., the umbilical cord blood stem cell preservation company which is focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today it salutes the news that the White House will back legislation that provides federal funding for stem-cell research using certain embryonic cells. Let us hear your thoughts below:

MondayApr 09, 2007 5:36 am

Cord Blood America Inc. (CBAI.OB) – Government Legislation May End Controversies

Cord Blood America is discovering ways to use stem cells to save lives internationally. Today they sent a press release announcing that the White House will be backing legislation which will provide funding for stem-cell research. The CEO of Cord Blood America stated it is important to increase the knowledge of stem cells in order to combat some of the most dangerous and difficult diseases. He continued to say, “umbilical cord blood stem cells are already used to treat more than 70 major diseases, including leukemia, metabolic blood disorders and immune deficiencies.” The umbilical cord blood stem cells that Cord…

FridayApr 06, 2007 2:41 pm

Cord Blood America Inc. (CBAI.OB) Sees Government Catching Up with the Science of Stem Cell Research

The White House is now backing legislation that provides federal funding for stem-cell research using embryonic cells that have no chance of surviving. The legislation, authored by Sen. Johnny Isakson, Georgia Republican, seeks a middle ground in the highly charged debate over stem-cell research. His bill skirts moral concerns over using embryonic stem cells while ensuring federal funding for the breakthrough science. Mr. Isakson's bill would allow scientists to conduct research on embryos they determine are incapable of surviving in the womb, but whose stem cells are still viable for research. Cord Blood America Inc. (CBAI.OB) is dedicated to becoming the industry…

ThursdayApr 05, 2007 12:25 pm

Cord Blood America (CBAI.OB) is a Leader in Stem Cell Therapy, as Science Reinvents Medicine

Cord Blood America, Inc. (CBAI.OB) is an emerging leader in the fast growing stem cell therapy industry. There is uniformity in science that stem cells will play a key role in fightling disease, as we move through this decade and beyond. Indeed, many believe that stem cells could launch a new era in medicine, perhaps even curing some of our most intractable diseases. The umbilical cord which, at birth, traditionally has been tossed away, contains a rich store of stem cells. Cord Blood America, Inc. markets a service to perserve the umbilical cord blood in a patented process, for future use exclusively by the…

TuesdayApr 03, 2007 5:02 pm

Offering a Potentially Life Saving Product, Cord Blood America, Inc. (CBAI.OB) is an Emerging Industry Leader

Cord Blood America, Inc. (CBAI.OB) offers an Industry leading approach with its no money down at birth plan, for this valuable, almost insurance like offering, for families. Their product is like an insurance policy, providing strong peace of mind. The preserved umbilical cord blood is saved specifically for the donating family. Besides current uses, medical research is ongoing on how to use these cells to combat heart disease, Parkinson’s disease, spinal cord injuries, sickle cell anemia, Multiple Sclerosis and other difficult diseases to treat. Researchers dream that the cells they remove from the umbilical cord blood can someday be turned into…

TuesdayApr 03, 2007 9:04 am

Cord Blood America, Inc. (CBAI.OB) is in Rapid Expansion Mode in its First Three Years of Operation

Cord Blood America, Inc. (CBAI.OB) continues to be following a rapid expansion business model. The Company is experiencing rapid growth in its first three years of operation. The Company finds itself in a growth industry. In 2003, only five percent of the four million women in the U.S> giving birth knew about perserving their umbilical cord blood and two percent of these took advantage of this life saving procedure. CBAI recently completed the acquisition of CorCell, Inc. of Philadelphia, PA., the fourth largest umbilical cord blood bank in America. In February, 2007 the Company secured $2M in capital, chosing to complete the funding as a…

MondayApr 02, 2007 3:54 pm

Evolving Stem Cell Therapies Supported by Cord Blood America, Inc. (CBAI.OB) have Broad Applications to Currently Treat 75 Diseases

Cord Blood America, Inc. (CBAI.OB) is the parent company of Cord Partners, Inc., which provides private umbilical cord blood stem cell storage services to families. CBAI has achieved rapid growth in its first three years of operation and expects to continue to experience growth as awareness of the cord blood industry grows. Cord Partners sells its service to expectant parents. Families elect to store stem cells from umbilical cord blood because these stem cells may be used to treat future illnesses in the donor child or other family members. At present, umbilical cord blood stem cells can be used to…

Site Search

Company Search

Tag: Cord Blood America Inc. CBAI